Supply of Aflibercept
Original notice title
Belgium – Pharmaceutical products – Raamovereenkomst voor het leveren van Aflibercept
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
30 / 100
Risk factors
Critical information such as estimated value, award criteria, and eligibility requirements are not available, hindering...
All documents and communications are in Dutch, which may exclude non-Dutch speaking bidders or increase translation cos...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- AZ Monica
- Country
- Belgium
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Sep 02, 2026
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Supply of Aflibercept (intravitreal drug for eye conditions) under a framework agreement.
- Place of performance: Antwerp province, Belgium (BE211).
Show full summary
This is an open procedure for a framework agreement (single operator) for the supply of Aflibercept, an intravitreal drug for eye conditions, to AZ Monica hospital in Belgium. The tender is published in Dutch only. The estimated value, award criteria, and selection criteria are not provided in the available data. Only the structured notice and XML notice were analyzed; no procurement documents were reviewed.
Risks
Critical information such as estimated value, award criteria, and eligibility requirements are not available, hindering...
All documents and communications are in Dutch, which may exclude non-Dutch speaking bidders or increase translation cos...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Tenderers must submit offers electronically via the specified submission URL.
- Procurement documents are available at the provided URL (in Dutch).
- The language of the procedure is Dutch (NLD).
Requirements may be incomplete.
Buyer
Name
Location
Deurne, BEL
Website
Buyer profile
Identifier
0459768815_1626
Activity
Health
Lots (1)
LOT-0001
Supply of Aflibercept
Framework agreement for the supply of Aflibercept, an intravitreal medicine used for eye conditions.
Location
Category
Deadline
Award details
Deze opdracht betreft een raamovereenkomst voor de levering van aflibercept. Aflibercept is een intravitreaal geneesmiddel toegepast bij oogaandoeningen.
Value note
Show original TED data
Original lot title
AD/VG/2025/025 - 1
Original TED description
Deze opdracht betreft een raamovereenkomst voor de levering van aflibercept. Aflibercept is een intravitreaal geneesmiddel toegepast bij oogaandoeningen.
Procurement Details
- Publication date
- 18 Jun 2026
- Languages
- Dutch
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 422370-2026
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
30 / 100
Risk factors
Critical information such as estimated value, award criteria, and eligibility requirements are not available, hindering...
All documents and communications are in Dutch, which may exclude non-Dutch speaking bidders or increase translation cos...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications